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Key messages
 ► Does 7-day specialist emergency care improve out-
comes in chronic obstructive pulmonary disease ex-
acerbations requiring hospitalisation?
 ► In both ventilated and non-ventilated patients, this 
model of care was associated with reduced mortality 
and length of stay; but a small increase in 90-day 
readmission rates.
 ► The potential implications of wider adoption of this 
model of care to both patients and healthcare pro-
viders are substantial.
AbstrAct
Introduction In exacerbation of chronic obstructive 
pulmonary disease (ECOPD) requiring hospitalisation 
greater access to respiratory specialists improves 
outcome, but is not consistently delivered. The UK National 
Confidential Enquiry into Patient Outcome and Death 
2015 enquiry showed over 25% of patients receiving 
acute non-invasive ventilation (NIV) for ECOPD died in 
hospital. On 16 June 2015 the Northumbria Specialist 
Emergency Care Hospital (NSECH) opened, introducing 
24/7 specialty consultant on-call, direct admission from 
the emergency department to specialty wards and 7-day 
consultant review. A Respiratory Support Unit opened 
for patients requiring NIV. Before NSECH the NIV service 
included mandated training and competency assessment, 
24/7 single point of access, initiation of ventilation in the 
emergency department, a door-to-mask time target, early 
titration of ventilation pressures and structured weaning. 
Pneumonia or hypercapnic coma complicating ECOPD 
have never been considered contraindications to NIV. After 
NSECH staff-patient ratios increased, the NIV pathway was 
streamlined and structured daily multidisciplinary review 
introduced. We compared our outcomes with historical and 
national data.
Methods Patients hospitalised with ECOPD between 1 
January 2013 and 31 December 2016 were identified 
from coding, with ventilation status and radiological 
consolidation confirmed from records. Age, gender, 
admission from nursing home, consolidation, revised 
Charlson Index, key comorbidities, length of stay, and 
inpatient and 30-day mortality were captured. Outcomes 
pre-NSECH and post-NSECH opening were compared and 
independent predictors of survival identified via logistic 
regression.
results There were 6291 cases. 24/7 specialist 
emergency care was a strong independent predictor of 
lower mortality. Length of stay reduced by 1  day, but 90-
day readmission rose in both ventilated and non-ventilated 
patients.
conclusion Provision of 24/7 respiratory specialist 
emergency care improved ECOPD survival and shortened 
length of stay for both non-ventilated and ventilated 
patients. The potential implications in respect to service 
design and provision nationally are substantial and 
challenging.
IntroductIon
Chronic obstructive pulmonary disease 
(COPD) is one of the most common diseases 
in the UK, with an estimated 3 million 
sufferers. Approximately 13% of over 35 
year-olds have COPD, and many are undiag-
nosed.1 2 COPD is characterised by airflow 
limitation and parenchymal lung destruction, 
frequently resulting in breathlessness, chest 
tightness, sputum production and exercise 
limitation among other symptoms.3 Exacerba-
tions of COPD (ECOPD), during which symp-
toms acutely worsen, are common. These 
episodes are often triggered by infection and 
are the second most frequent cause of emer-
gency hospital admission in the UK, occur-
ring predominantly in older patients. Patients 
who survive to discharge have a high risk of 
recurrent ECOPD and readmission, particu-
larly within 90 days of discharge.4–7 The 
annual direct primary and secondary health-
care cost of COPD to the National Health 
Service (NHS) is approximately £1.85 billion.8 
Despite improvements in care, there is still 
excess COPD mortality in the UK compared 
with other European countries (age-stand-
ardised mortality rate: UK=58.8; EU 28=34.9 
deaths/100 000).4 9 10 In ECOPD complicated 
by respiratory acidaemia, non-invasive ventila-
tion (NIV) substantially improves survival and 
reduces the need for invasive ventilation.11 12 
In the UK, in-hospital mortality for ECOPD 
requiring NIV is over 25% , substantially 
higher than the rates reported in clinical 
trials, and raises concern.13 The 2003 national 
audit showed that specialist respiratory care 
in COPD reduced length of stay (LOS) and 
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both inpatient and 90-day mortality.14 Further to this, the 
2014 national COPD audit report showed that patients 
seen by respiratory specialists received better evidence-
based care and highlighted the need to improve access 
to respiratory physician-led care.15 The North East of 
England has among the highest COPD prevalence and 
mortality in the UK.16
the northumbria model
Northumbria Healthcare NHS Foundation Trust serves 
a population of 519 000 across a large geographical area 
in the North East of England. Previously, three district 
general hospitals accepted emergency admissions; one 
served a predominantly urban population, two included 
substantial rural populations and there was consider-
able socioeconomic diversity. Most admissions arrived in 
hospital via an emergency department (ED), which did 
not have 24/7 consultant presence. Two hospitals ran an 
acute medical admissions unit, and all relied on general 
physicians to provide acute consultant care. This broadly 
reflects current UK structures of care.
On 16 June 2015 the Northumbria Specialist Emer-
gency Care Hospital (NSECH) opened as the first 
purpose-built specialist emergency care hospital in 
England,17 receiving all emergency admissions, including 
primary care referrals. All patients are assessed in the ED 
with direct specialty ward admission. NSECH has dedi-
cated inpatient diagnostic services, not competing with 
outpatient demand. Consultants in all major special-
ties are present at least 12 hours/day, 7 days/week and 
are on-call overnight. Consultants in ED are present at 
all times. If ongoing hospital care is needed once clin-
ically stable, patients are transferred to an appropriate 
specialty ward in a different hospital within the trust. 
Risk-stratification tools are routinely used to inform clin-
ical care, including Dyspnoea Eosinopenia Consolidation 
Acidaemia and atrial Fibrillation score (DECAF)18 19 in 
ECOPD. Low-risk patients (DECAF 0–1) are considered 
for direct discharge from ED or formal hospital at home, 
while high-risk scores inform antibiotic choice among 
other aspects of care.20
NSECH houses an 11-bed Respiratory Support Unit 
(RSU) in which patients treated with acute NIV receive 
1:2 care, with ventilation delivered by dedicated non-in-
vasive ventilators (Respironics V60, providing controlled 
FiO2 21%–100%) and a range of interfaces. There is a 
single point of access to acute NIV, which is provided 
by NIV trained and competency assessed physiother-
apists who strictly adhere to our NIV pathway (online 
supplementary figure E1); NIV is only used outside these 
criteria with the approval of respiratory or intensive care 
consultants. On hospital arrival, and increasingly from 
ambulance pick-up, administering controlled oxygen 
to meet specified target saturations is the default; ED 
arrival is the start of the controlled oxygen trial. Most 
patients will receive nebulised bronchodilators early after 
arrival in the ED, or in the ambulance prior, thus other 
medical therapy likely to influence correction of respi-
ratory acidaemia is included in the controlled oxygen 
trial period. A door-to-mask time target establishes the 
recognition and treatment of respiratory acidaemia as 
a medical emergency. NIV is commenced in the area 
the patient presents, normally the ED, before transfer 
to the RSU once the patient is stabilised. In conditions 
with favourable outcomes to NIV such as COPD, obesity 
hypoventilation syndrome and neuromuscular disease, 
consultant approval prior to NIV treatment is not 
required, but is necessary in all other cases. Hypercapnic 
coma and pneumonia complicating a condition with a 
known favourable response to NIV are considered indi-
cations for close monitoring, but not contraindications 
to NIV. An NIV prescription is required and includes: 
escalation and resuscitation plans; documentation of 
monitoring blood gases; and consequent changes to 
ventilation settings.
The NSECH RSU contains point-of-care arterial blood 
gas testing, dual oxygen ports, compressed air to drive 
nebulisers and transcutaneous CO2 monitoring avail-
ability. There have been incremental changes to the NIV 
pathway since 2003 (figure 1), and it was further stream-
lined in 2016 where changes included:
 ► Limiting the role of controlled oxygen trials 
(maximum of 60 min from hospital arrival; but 
if severe acidaemia (pH <7.25) is present or the 
patient is rapidly deteriorating NIV can be initiated 
immediately).
 ► Removing the requirement for patients to have a 
pre-NIV chest radiograph in the high-risk groups 
above provided there is no clinical indication of pneu-
mothorax (an urgent radiograph is still requested).
 ► Reduction in door-to-mask time target from 180 to 
120 min.
 ► Introduced a structured ‘daily review’ meeting led by 
an experienced NIV physiotherapist to discuss and 
action:
 – Ventilation settings.
 – Weaning plans.
 – Consideration of/referral for home ventilation.
 – Referral to pulmonary rehabilitation.
 ► Expansion of NIV training to involve use of a simula-
tion suite and wide range of cases.
The NIV protocol includes ventilator settings and a 
weaning strategy specific to the condition being treated, 
closely maps to the 2018 BTS NIV Quality Standards21 
and is subject to continuous rolling audit.
We aimed to assess whether the major changes in the 
structure of care following the opening of NSECH were 
associated with an improvement in outcomes following 
hospital admission for ECOPD, in both patients requiring 
and not requiring assisted ventilation. Outcomes assessed 
include mortality (inpatient, 30 days after discharge 
and combined inpatient plus 30 days after discharge), 
LOS and readmission rate at both 30 and 90 days after 
discharge.
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Figure 1 Timeline of changes to the Northumbria non-invasive ventilation pathway between 2003 and 2017. COPD, chronic 
obstructive pulmonary disease; NIV, non-invasive ventilation; NSECH, Northumbria Specialist Emergency Care Hospital; RSU, 
Respiratory Support Unit.
Methods
Patients hospitalised with ECOPD between 1 January 
2013 and 31 December 2016 were identified from 
coding data using either a primary diagnosis code of J44 
(which captures COPD exacerbation) or J96 (respira-
tory failure) with a secondary code of J44. Patients 
under 35 years old were excluded. Inpatients prior to, 
and at the time of, NSECH opening were categorised as 
pre-NSECH. Patients admitted from 16 June 2015 were 
considered post-NSECH. Patients requiring assisted 
ventilation at any point during this admission (defined 
as NIV or invasive mechanical ventilation (IMV), but 
not continuous positive airway pressure (CPAP)), were 
identified through our internal rolling NIV audit data 
and the coding search, with discrepancies resolved 
through case note review. Coding data do not differen-
tiate between CPAP and NIV; a problem highlighted in 
the recent National Confidential Enquiry into Patient 
Outcome and Death (NCEPOD) report on NIV.13
Age, sex, admission from residential/nursing home, 
revised Charlson Index (as used in the Summary 
Hospital-Level Mortality Indicator (SHMI),22 but with 
COPD scoring removed), key comorbidities including 
dementia, cardiovascular disease, stroke and active 
malignancy (for full list see online supplementary file 
1), and whether the patient was under the care of a 
respiratory physician or admitted to the critical care 
unit during their hospital stay were collected. Chest 
radiograph reports were reviewed and presence of pneu-
monia or heart failure (such as pulmonary congestion, 
bilateral effusions, pulmonary oedema) was recorded.
In-hospital and 30-day postdischarge mortality, LOS 
and readmission rates pre-NSECH and post-NSECH 
opening were captured. We examined changes in 
mortality rates (combined 30 days and inpatient) by day 
of admission (weekday/weekend), and the proportions 
of weekday versus weekend discharges pre-NSECH and 
post-NSECH.
Data are presented as mean (SD), median (IQR) 
and absolute number (percentage), while bivariate 
comparisons were made using Student’s t-test, Mann-
Whitney U test and Fisher’s exact test for parametric, 
non-parametric and categorical variables, respectively. 
NSECH, age, gender, season, consolidation, dementia, 
cardiovascular disease, revised Charlson Index22 and 
admission from institutional care (nursing or residen-
tial home) were included in a stepwise logistic regres-
sion model using backward elimination techniques 
and checked for collinearity. The final regression 
model was checked for robustness, fit with reference 
to tolerance and residual and eigenvalue patterns. This 
was performed for both ventilated and non-ventilated 
subgroups. In the regression models, the term ‘full 
model’ refers to all variables of interest, not restricted 
to those significantly related to mortality, and the term 
‘independent predictors model’ refers to a reduced 
model showing only those variables which were inde-
pendent predictors of mortality. The full model is 
shown to illustrate the interaction between all possible 
variables of interest.
A variable life adjusted display (VLAD) chart was 
plotted. This is a graphical method to demonstrate 
observed versus expected mortality, adjusted for the 
baseline mortality risk. It demonstrates the cumula-
tive number of excess deaths (below the x-axis) or 
lives saved (above the x-axis) compared with expected 
outcome. The baseline risk was set as the SHMI January 
2013 to December 2013 model; chosen as this is the 
first year of our data. Analyses were performed using 
IBM SPSS V.24.
results
A total of 3943 ECOPD episodes were identified before 
NSECH opening and 2348 afer NSECH opening. Eight 
patients were coded as having received NIV but records 
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Table 1 Key demographics and outcomes split by ventilation status pre-NSECH and post-NSECH
Pre-NSECH Post-NSECH P values
All patients: demographics
Age mean (SD) 72.64 (10.7) 72.01 (10.5) 0.023
NIV (%) 521 (13.2) 339 (14.4) 0.17
NIV+IMV/IMV alone   10/19   6/7 –
% ventilated patients who received IMV 5.4 3.8 0.33
Under respiratory consultant (%) 1994 (50.6) 1638 (69.8) <0.0001
Critical care admission (%) 73 (1.9) 38 (1.6) 0.55
CXR with pneumonia (%) 782 (19.8) 402 (17.1) 0.0077
Charlson Index median (IQR) 3.00 (0–10) 3.00 (0–12) 0.011
Admitted from institutional care (%) 217 (5.5) 133 (5.7) 0.82
Non-ventilated patients: outcomes
Mortality: IP+30 days after discharge (%) 211 (6.2) 87 (4.3) 0.0037
Mortality: IP only (%) 152 (4.5) 58 (2.9) 0.0035
Mortality: OP ≤30 days after discharge (%) 59 (1.7) 29 (1.4) 0.50
Median LOS (IQR) 4 (1–7) 3 (1–7) 0.0023
Readmission: 30 days (%) 865 (25.4) 522 (26.1) 0.61
Readmission: 90 days (%) 1343 (39.5) 854 (42.7) 0.022
Ventilated patients: outcomes
Mortality: IP+30 days after discharge (%) 98 (18.1) 36 (10.4) 0.0015
Mortality: IP only (%) 71 (13.1) 32 (9.2) 0.086
Mortality: OP ≤30 days after discharge (%) 27 (5) 4 (1.2) 0.0022
Median LOS (IQR) 9 (6–15) 8 (5–13) 0.0015
Readmission: 30 days (%) 127 (23.5) 101 (29.2) 0.070
Readmission: 90 days (%) 200 (37) 165 (47.7) 0.0021
Data are mean (SD), median (IQR) or absolute number (%).
IMV, invasive mechanical ventilation;IP, inpatient;LOS, length of stay;NIV, non-invasive ventilation;NSECH, Northumbria Specialist Emergency 
Care Hospital;OP, outpatient.
could not be obtained. These patients have been classi-
fied as having had NIV. Sixty radiographs with unclear 
reports were reviewed, and a further 45 cases without 
a chest X-ray were assumed not to have pneumonia or 
heart failure. Patient characteristics were broadly similar 
between the pre-NSECH and post-NSECH groups 
although, as expected, post-NSECH patients were more 
likely to be under respiratory consultant care and had 
slightly lower rates of coexistent radiographic consoli-
dation. Fewer than 2% of all patients with ECOPD were 
admitted to critical care, and among ventilated patients 
there was a non-significant reduction in the proportion 
receiving IMV from 5.4% pre-NSECH to 3.8% post-
NSECH (table 1).
After NSECH, inpatient plus 30-day mortality and 
LOS were lower in both ventilated and non-ventilated 
patients. However, the 90-day readmission rate was 
higher in both groups. In ventilated patients there 
was a substantial fall in 30-day postdischarge mortality, 
with a trend towards a higher 30-day readmission rate 
(table 1). The VLAD plot (figure 2) showed sustained 
improvement in observed versus expected mortality. 
Our median (IQR) door-to-mask times were 109 (99) 
min before NSECH and 114 (114) min after NSECH.
NSECH was a strong predictor of reduced mortality 
in both ventilated (OR 0.52; 95% CI 0.34 to 0.78) and 
non-ventilated (OR 0.68; 95% CI 0.52 to 0.89) patients. 
The independent predictors identified in the regres-
sion analysis for both ventilated and non-ventilated 
patients are shown in table 2.
The opening of NSECH did not impact the pattern 
of mortality based on weekday versus weekend admis-
sions. Mortality in patients admitted over a weekend 
was non-significantly lower compared with those 
admitted on a weekday, both pre-NSECH and post-
NSECH. The proportion of patients discharged at the 
weekend increased following the opening of NSECH 
(table 3).
Details of the remaining bivariate comparisons 
between pre-NSECH and post-NSECH groups (online 
supplementary table E1), as well as the full regression 
analysis tables (online supplementary tables E2 and E3) 
are available online supplementary file 1.
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Figure 2 Variable life adjusted display (VLAD chart) showing observed versus expected mortability with cumulative lives lost 
below the x-axis and cumulative lives saved above the x-axis. NSECH, Northumbria Specialist Emergency Care Hospital.
Table 2 Backward regression analysis showing our independent predictors only. Results displayed for ventilated and non-
ventilated patients
Independent predictors B OR (95% CI) P values
Non-ventilated patients
Age (years) 0.052 1.05 (1.04 to 1.07) <0.0001
Any cardiovascular disease 0.315 1.37 (1.05 to 1.80) 0.022
CXR evidence of pneumonia 0.284 1.33 (1.01 to 1.76) 0.046
Post-NSECH −0.383 0.68 (0.52 to 0.89) 0.0042
Charlson score 0 <0.0001
Charlson score 1–5 −0.137 0.87 (0.57 to 1.32) 0.52
Charlson score >5 0.802 2.23 (1.65 to 3.02) <0.0001
Admission from nursing home 0.624 1.87 (1.29 to 2.70) 0.0010
Ventilated patients
Age (years) 0.050 1.05 (1.03 to 1.07) <0.0001
Male −0.489 1.63 (1.10 to 2.41) 0.014
Post-NSECH −0.663 0.52 (0.34 to 0.78) 0.0018
Charlson score 0 0.0083
Charlson score 1–5 −0.840 0.43 (0.24 to 0.78) 0.0054
Charlson score >5 0.031 1.03 (0.67 to 1.58) 0.89
Full list of cardiovascular diseases and/or stroke diseases is found in the online supplementary file 1.
B, beta coefficient;CXR, chest X-ray;NSECH, Northumbria Specialist Emergency Care Hospital.
dIscussIon
The NSECH model of 24/7 specialist emergency care was 
associated with lower ECOPD mortality and LOS, both 
in ventilated and non-ventilated patients. Improvements 
were seen from a strong baseline; NIV mortality rates 
pre-NSECH were lower than the NCEPOD Inspiring 
Change report and the 2013 BTS NIV audit.13 23 In a 
logistic regression model including the available poten-
tial prognostic indices, NSECH was independently associ-
ated with survival for both ventilated and non-ventilated 
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Table 3 Weekday and weekend discharges and mortality. 
Outcomes pre-NSECH and post-NSECH opening have 
been compared by Fisher’s exact test
Weekday 
(Monday to 
Friday)
Weekend 
(Saturday and 
Sunday) P values
Day of discharge (% of all discharges)
Pre-NSECH 87.8 12.2 0.0019
Post-NSECH 84.9 15.1
Combined inpatient and 30-day postdischarge mortality 
(based on day of admission)
Pre-NSECH % 
(n=3943)
8.1 7.0 0.28
Post-NSECH % 
(n=2348)
5.5 4.6 0.46
NSECH, Northumbria Specialist Emergency Care Hospital.
patients. Key strengths of this study include a large 
sample size, broad inclusion criteria and verification of 
ventilation status and chest radiograph appearance from 
patient records. There was no significant difference in 
mortality based on weekday or weekend admission, but 
rather a global improvement across 7 days.
Survival improved after NSECH and compares favour-
ably to similar populations nationally and internation-
ally.23–26 The model of care is a complex intervention 
and it is impossible to identify the relative contribution 
of individual components. Nevertheless, we consider 
early access to specialist respiratory care important, 
complementing the findings and recommendations of 
the 2014 national audit.15 Provision of specialist care has 
been shown to improve outcomes in other conditions. 
In heart failure, patients managed by cardiologists have 
better in-hospital and 1-year survival compared with 
those under other physicians.27–29 This pattern is similar 
in other conditions such as inpatient treatment of myas-
thenia gravis, Parkinson’s disease and end-stage liver 
disease.30–32 The proportion of patients under a respira-
tory consultant increased; we have not captured respira-
tory review of patients on other medical wards, but who 
are not under the direct care of a respiratory consultant, 
a limitation of coding data. The respiratory specialist 
nurses review all such patients identified. Changes in care 
are common and likely to influence outcomes, but not 
captured by coding. The case mix, or severity of illness, 
cannot be measured from coding data and thus compar-
isons of case mix between patients under respiratory or 
other care are not examined.
Provision of 1:2 care during the acute period of NIV 
was introduced with the opening of the RSU in NSECH. 
Other elements of NIV provision described were already 
in place, but delivery is likely to have been more consis-
tent in NSECH. Use of controlled oxygen to target satu-
rations is encouraged from ambulance pick-up and is 
the default from ED arrival. Austin et al showed that in 
patients with suspected ECOPD, controlled oxygen from 
ambulance pick-up improved survival in those subse-
quently confirmed to have airflow obstruction, while 
other patients were not harmed.33 Furthermore, the UK 
National COPD Resources and Outcomes Project data 
show that use of high-flow oxygen is associated with higher 
rates of ventilation (high-flow oxygen: used=22%; not 
used=9%) and mortality (high-flow oxygen: used=11.1%; 
not used=7.2%).34 This supports provision of controlled 
oxygen to target saturations by default in all patients with 
COPD, rather than reliance on oxygen alert cards or 
selection by other means. We initiate NIV in the setting 
in which the patient first presents (normally the ED) to 
reduce delays in treatment. The NCEPOD report showed 
that 28% of patients were transferred to the ward before 
starting treatment with NIV, and 24% of these had an 
unnecessary delay to their treatment.13 Delay in life-saving 
treatment while awaiting ward transfer is a common and 
avoidable problem; both NCEPOD and the BTS NIV 
Quality Standards recommend our approach.13 21 While 
NIV was consistently provided by NIV-trained and compe-
tency-assessed clinicians (predominantly physiothera-
pists) throughout, before NSECH monitoring and review 
were more robust. Structured daily progress review led 
by a senior respiratory physiotherapist was introduced, 
including ventilation and weaning plans, and consider-
ation for home ventilation. The NCEPOD report high-
lights that provision of NIV by staff without training and 
competency assessment and inadequate monitoring 
during provision of NIV are common failings. We provide 
our NIV guideline and wall chart as an online supplemen-
tary file 1, and direct clinicians to the BTS Quality Stan-
dards21 and NCEPOD self-assessment checklist (http://
www. ncepod. org. uk/ 2017niv. html). Rates of IMV vary 
markedly between hospitals and countries,35 and the rela-
tively low rates in the UK may in part reflect fewer critical 
care beds and nihilism.36 However, the outcome from 
IMV following failure of NIV is poor.37 One possibility is 
that this reflects inappropriately delayed intubation, but 
it may be that a population failing despite high-quality 
NIV and appropriate medical therapy represent a distinct 
group in whom IMV is unlikely to improve outcome 
due to the severity of their underlying lung disease and 
acute insult. These patients may have a poor outcome 
regardless of how ventilation is provided and should be 
differentiated from those failing due to poor tolerance 
of the non-invasive interface, in whom escalation to 
IMV is more appropriate. Of relevance, before and after 
NSECH, patient characteristics and the proportion venti-
lated per day (pre-NSECH=0.60; post-NSECH=0.61) were 
similar, yet the NSECH model of care was associated with 
a substantial fall in inpatient and 30-day mortality among 
ventilated patients (18.1% vs 10.4%) despite a non-signif-
icant fall in the proportion receiving IMV (5.4% vs 3.8%).
The proportion of our patients discharged at the 
weekend has increased but, in both groups, 90-day read-
mission rates were higher after the opening of NSECH, 
following a national trend. The largest increase in read-
missions following NSECH opening was between 30 
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and 90 days after discharge, suggesting that this was not 
primarily due to suboptimal acute management. The 
Previous admissions, Extended MRCD score, Age, Right 
and Left-sided heart failure (PEARL) score highlights 
that frailty and comorbidities are important drivers of 
readmission,7 and thus potential targets for intervention 
that are easily overlooked if excessive focus is placed 
on the respiratory features alone. While reducing read-
mission rates in ECOPD is a priority,15 it is important 
to consider that readmission may not universally be an 
adverse event. For example, before NSECH, the venti-
lated population experienced a substantial fall in 30-day 
postdischarge mortality and a corresponding trend 
towards more frequent readmission. The national trend 
in readmissions for ECOPD is multifactorial; reasons 
may include a lower threshold for referral to hospital, an 
ageing and more comorbid population and a change in 
attitude to risk. However, our data suggest that for some 
individuals, early hospital readmission may be protective.
The main weaknesses of this study are reliance on 
a single centre, its retrospective nature and the use of 
coding data which may misattribute diagnoses or miss 
patients. Compared with a population with spirometry 
confirmed COPD, outcomes based on coding data may 
be better. Change in coding practice or diagnostic terms 
used by clinicians could also influence results; there was 
no change in coding definitions or the seasonally adjusted 
number of patients admitted with ECOPD over the study 
period. Population characteristics were similar; minor 
differences in age and pneumonia rates, both lower in 
the NSECH population, were balanced by greater comor-
bidity. Survival data are also for events rather than unique 
patients, relevant to those experiencing recurrent admis-
sions. This study is unable to identify the precise cause(s) 
of reduced mortality. Given the use of coding data, some 
clinical information with known prognostic implications, 
such as DECAF or Extended Medical Research Council 
Dyspnoea score (eMRCD),19 38 was not available in the 
study. Additionally, arterial blood gas measurements were 
unavailable to ensure all patients treated with NIV were 
appropriate; however, we have included our NIV guide-
line in the online supplementary file 1, and NIV is only 
initiated by the Respiratory Team or Critical Care. The 
onset of the sustained improvement in the VLAD survival 
chart predated the opening of NSECH. This could be as 
a result of there being 43 900 excess winter deaths nation-
ally39 (reflected in our local data) immediately prior to 
the pre-NSECH survival improvement; mortality rates 
may have transiently fallen due to regression to the mean. 
Additionally, where possible planned system changes were 
implemented at the pre-existing acute receiving hospitals 
in advance of NSECH opening; this may have impacted 
survival. It is also noteworthy that mortality has fallen 
in national COPD audits, with an inpatient mortality of 
4.3% in 2014 compared with 7.8% in 2008.15 We have 
not assessed whether similar improvements were seen in 
other conditions and specialities and it may be that our 
results in part reflect improving national outcomes.
Provision of 24/7 respiratory specialist emergency care 
was associated with improved ECOPD survival and short-
ened LOS in both non-ventilated and ventilated patients. 
The potential implications in respect to service design 
and provision nationally are substantial and challenging; 
confirmation of improved outcome in other conditions 
and NHS trusts is first required. Provision of this model 
of care did not stem the increase in the 90-day readmis-
sion rate, which may at least in part reflect lower acute 
mortality. Effective strategies to reduce the risk of read-
mission are urgently required.
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